Concepedia

S Brown

SB

Statistics

Publications

4

Citations

703

H-Index

4

Active since

2006

Affiliations

AstraZeneca (United Kingdom)(Current)

S Brown is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacology.

Publications per year

2006–2020

4

Publications

4

Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor

M. Raymond V. Finlay, Mark J. Anderton, Susan Ashton et al. · Journal of Medicinal Chemistry · 2014 · 602 citations · Full text

Medicine, Oncology, Pharmacology +15

Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT

Jason G. Kettle, S Brown, Claire Crafter et al. · Journal of Medicinal Chemistry · 2012 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre

Sue Cheeseman, Matthew D. Thompson, Will Sopwith et al. · Frontiers in Oncology · 2020 · 31 citations · Full text

Medicine, Oncology, Urology +10

Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides

John G. Cumming, S Brown, Anne Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

1–4 of 4